(Q40755952)

23 September 2017

title

Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia (English)

1 reference

23 September 2017

1 reference

1 reference

Meunier F

1

1 reference

23 September 2017

Van der Auwera P

series ordinal

2

1 reference

23 September 2017

Aoun M

series ordinal

3

1 reference

23 September 2017

Bron D

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

British Journal of Haematology

23 September 2017

published in

1 reference

23 September 2017

volume

76 Suppl 2

1 reference

23 September 2017

page(s)

49-53

1 reference

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Therapy of small cell lung cancer: anything new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Increasing incidence of Gram-positive sepsis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

In vitro activity and human pharmacokinetics of teicoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Gram-positive infections in granulocytopenic patients: an important issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07937.X

10.1111/J.1365-2141.1990.TB07937.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference